Tipsheet
What matters at India’s listed companies
Earnings · Pharmaceuticals · Micro cap

BDH Industries posts 44% revenue growth, but profit didn't follow.

A ₹210 crore pharma firm reports its best topline year, while profit growth trails far behind.

1 earlier story on BDH Industries Ltd.
Mkt cap₹259 cr
P/E23.96×
ROE13.49%
Debt / eq.0.01
Div yld1.15%
44% Year-on-year revenue growth for FY26.

What's new

  • Annual revenue grew 44% to ₹9,595 lakhs.
  • Profit after tax rose 16.6% to ₹1,081 lakhs.
  • Board recommended a ₹5 per share dividend.

Why this matters

Revenue growth is strong for a company of this size. The gap between sales and profit growth, however, means BDH is spending heavily to chase that top line, compressing its earnings conversion.

What we're watching

  • Whether the 44% topline growth rate can hold in FY27.
  • The margin trend as costs outpace revenue growth.
  • The record date and total cash outlay for the ₹5 dividend.

The full read

BDH Industries grew its top line by 44% to ₹9,595 lakhs in FY26. That's a big jump for a nano-cap pharma company. Profit didn't follow. Profit after tax rose 16.6% to ₹1,081 lakhs. The board is also recommending a ₹5 per share dividend alongside these audited results. The results are a scheduled disclosure. The 44% topline growth is the standout. The gap between sales and profit expansion is the follow-up question. The dividend is a return of cash from a small business that just posted its best year.

Questions answered

How did BDH Industries' annual results look?
For the year ended March 31, 2026, revenue grew 44% to ₹9,595 lakhs. Profit after tax grew 16.6% to ₹1,081 lakhs.
What is the dividend announcement?
The board recommended a ₹5 per share dividend. The filing does not specify the total payout or record date.
Why is profit growth lagging the revenue growth?
The filing does not detail reasons, but profit grew 16.6% against 44% revenue growth, implying costs rose faster than sales during the year.
Mentioned: BDH Industries · ₹5 dividend · ₹210 crore market cap
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

BDH Industries Ltd.

Pharmaceuticals
₹211 cr
P/E 19.53×

Latest quarter · Mar 2026

Sales₹29 cr
Net profit₹3 cr
Op. margin+14.5%
EPS₹5.00

Strength & growth

Debt / equity0.01×
Current ratio3.95×
Sales CAGR+7.6%
EPS CAGR+12.3%
Financials via Tijori — a research aid, not investment advice.MBIND on Tijori

Story so far

All notes on MBIND →
  1. 21 May 2026 · 6:57 PM IST BDH Industries posts 44% revenue growth, but profit didn't follow.
  2. 46d ago BDH Industries posts 44% revenue growth, ₹5 dividend